Startups
Prevencio utilizes Machine Learning (Artificial Intelligence) + Multi-Proteomic Biomarkers + Proprietary Algorithms to deliver cardiovascular diagnostic & prognostic tests that are significantly more accurate than standard-of-care stress tests, individual biomarkers, genetic markers and clinical risk scores.
Overview
Employees
11-50
Founded date
2013
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 14, 2026 | American Medical Association Awards Prevencio Fourth Proprietary CPT® Billing Code for AI-Powered HART PAD Blood Test | Prevencio logo Proprietary CPT billing code further strengthens commercialization and reimbursement foundation for Prevencio's scalable HART® AI-driven diagnostics platform. Prevencio is building the Exact Sciences (known for Cologuard®) of... |
| Mar 25, 2026 | Prevencio Selected for American College of Cardiology’s Scientific Sessions Innovation Hub | Prevencio HART AI Blood Tests Prevencio’s inclusion in ACC's Innovation Hub is an honor and reflects our commitment to advancing innovative, accessible, and accurate AI-driven blood tests for clinical use.” — Rhonda Rhyne, CEO & Chief T... |
| Jan 8, 2026 | Prevencio and Quadrant Health Announce Partnership to Integrate HART CVE and HART CADhs AI-Blood Tests into Primary Care | Prevencio HART AI Blood Tests Partnership expands access to AI cardiometabolic risk insights to support earlier detection, clearer triage, and more personalized care pathways By integrating HART blood tests into primary care workflows, clin... |
| Oct 22, 2025 | Prevencio Awarded Additional Patents for HART CADhs, Its AI-Driven Blood Test for Coronary Artery Disease | Prevencio HART AI Blood Tests Securing patent protection in the United Kingdom and Hong Kong complements U.S., European, and Japanese patent protection and marks another milestone in advancing our innovation and market leadership.” — Rhonda... |
| Sep 18, 2025 | Prevencio Enters National GPO Agreement with MediGroup to Expand Access to AI-Powered Cardiovascular Blood Tests | Prevencio HART AI Blood Tests This agreement with MediGroup accelerates our mission to make novel cardiac diagnostics widely accessible and validates the clinical utility and commercial readiness of our HART platform and tests.” — Rhonda Rh... |
| Jul 22, 2025 | Prevencio Enters Canadian Market Through Strategic Partnership with Heart Fit Clinic | Prevencio HART AI Blood Tests This partnership marks a key step in our international expansion and reflects strong alignment with clinically sophisticated partners focused on early detection and prevention.” — Rhonda Rhyne, Prevencio CEO KI... |
| Jul 25, 2023 | Massachusetts General Hospital Researchers and Prevencio Announce the Power of Artificial Intelligence HART Platform | AI-driven HART platform has produced seven highly accurate multiple protein blood tests presented in 32 peer-reviewed manuscripts and presentations Prevencio, the AI-Powered Cardiac Blood Test Company, announces the culminative presentation... |
| Nov 5, 2022 | Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 5th November 2022 | This is our AI Daily Roundup today. We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and hu... |
| Nov 4, 2022 | Massachusetts’s General Hospital Study Demonstrates Prevencio’s AI-driven HART CVE Blood Test Highly Accurate | AI-driven, multiple protein blood test data presented at 2022 American Heart Association Scientific Sessions Prevencio, announces the presentation of patient data demonstrating its Artificial Intelligence (AI)-driven HART CVE blood test is ... |
Show more
Reviews 0
FAQ about Multi
When was Multi founded?
Multi was founded in 2013.
What has the press written about Multi?
Parsers VC has collected 12 articles mentioning Multi, among them “American Medical Association Awards Prevencio Fourth Proprietary CPT® Billing Code for AI-Powered HART PAD Blood Test” (Jul 14, 2026) and “Prevencio Selected for American College of Cardiology’s Scientific Sessions Innovation Hub” (Mar 25, 2026).
Is Multi still active?
Yes, Multi is active; its latest activity on Parsers VC dates from Aug 25, 2026.